Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

HBI-8000 × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 552 Specimen Handling 541 Magnetic Resonance Spectroscopy 449 Carboplatin 363 Cyclophosphamide 331 Biopsy 314 Cisplatin 303 Paclitaxel 267 Nivolumab 261 Radiotherapy 238 Gemcitabine 236 Bevacizumab 199 Dexamethasone 191 venetoclax 180 fludarabine 179 Docetaxel 161 Oxaliplatin 160 durvalumab 155 atezolizumab 155 Fluorouracil 155 Pemetrexed 149 Rituximab 148 Capecitabine 141 Doxorubicin 136 Radiation 132 Standard of Care 126 Drug Therapy 126 Prednisone 124 Lenalidomide 124 Radiosurgery 122

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05141357 2025-12-24

HBI-8000

HUYABIO International, LLC.

Phase 2 Terminated

5 enrolled 8 charts

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡